New hope drug enters human testing for Tough-to-Treat cancers
Disease control
Not yet recruiting
This early-stage study is testing a new drug called XNW34017 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shows any signs of fighting the cancer. The study will enroll about 15…
Phase: PHASE1, PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC